Each conjugate comprises antigen covalently bound to horseradish peroxide and is suitable as a tracer in immunoassay development.
Nature
Synthetic
Tag/Conjugate
HRP
Alternative Names
Dehydromethyltestosterone 3, CDMT
Format
The conjugate is supplied as a concentrate. Dilute as required and use working strength conjugate immediately after dilution
Preservative
None
Storage
2 - 8°C for up to 3 months / -20°C for long term storage
Introduction
Chlorodehydromethyltestosterone (CDMT) (brand name Oral Turinabol) is an androgenic-anabolic steroid. It is the 4-chloro-substituted derivative of metandienone (dehydromethyltestosterone) (Dianabol). CDMT was the first original product of Jenapharm, an East German pharmaceutical company. The patent registration took place in 1961. The idea of combining the structures of 4-chlorotestosterone (clostebol) and metandienone originated from the chemist Albert Stachowiak.[citation needed] At the time this represented a unique dissociation of anabolic and androgenic effects after oral administration.[1] The product had been introduced for clinical use in 1965. CDMT was the key steroid administered to approximately 10,000 athletes from East Germany (GDR). The doping program was run by the East German Government from about 1968 until 1989 when the Berlin wall was destroyed. The doping program was known as STASI 14.25. The doping was done in secret and it was only in the 1990s when Franke and Berendonk looked closely at the original archived information and discovered the true scope of just how well-planned and successful the doping regime had been (in terms of medal success and world record performances).
Citations
Publication ()
Have you cited DAGB323 in a publication? Let us know and earn a reward for your research.
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.